• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS MEDICAL ASD, INC. CLEO 90 SUBCUTANEOUS INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS MEDICAL ASD, INC. CLEO 90 SUBCUTANEOUS INFUSION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 21-7230-24
Device Problems Fluid/Blood Leak (1250); Leak/Splash (1354)
Patient Problem Cellulitis (1768)
Event Date 10/05/2018
Event Type  malfunction  
Manufacturer Narrative
This mdr was generated under protocol (b)(4), as a result of warning letter cms# (b)(4).A device history record (dhr) review was conducted which indicated all inspections were completed and no issues were noted during manufacture.A product sample was received for evaluation.Visual and functional testing were performed.The samples were visually inspected, at a distance of 12 to 24 and normal conditions of illumination.All the samples were received with the skin adhesive stuck on the white cap, one (1) sample was received without the base and cannula.The sample received with the base and cannula was tested using a buckle assembly taken from the production line to replicate the failure mode.No leaks were detected in the samples.A review of the manufacturing process for was conducted by quality engineer in order to verify that there are no situations or practices that could create the event.No discrepancies were found.The root cause of the reported event was found to be excessive voids in the static bond on the patch, which may be inherited in the raw material or created during conversion and/or assembly processes.Incoming lots are inspected and reword process are in place to ensure the patch lifted above 0.030 are reworked.A new inspection fixture was designed and developed to decrease that measurement variability to 0.005.The inspection fixture was improved under the procedure to accurately determine whether our product meets the 0.030 lift acceptance criteria.A new packaging configuration was implemented which the cleo devices are stored in a cap up orientation.A corrective and preventative action has been opened to address the reported issue.
 
Event Description
It was reported that a leakage has been observed under the adhesive part during the infusion; usually 1 hour or 2 hours after.The patient had redness in the insertion site.No medical or surgical intervention was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEO 90 SUBCUTANEOUS INFUSION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS MEDICAL ASD, INC.
6000 nathan lane north
minneapolis MN 55442
Manufacturer (Section G)
SMITHS MEDICAL ASD, INC.
6000 nathan lane north
minneapolis MN 55442
Manufacturer Contact
jim vegel
6000 nathan lane north
minneapolis, MN 55442
MDR Report Key15666331
MDR Text Key306727414
Report Number3012307300-2022-26120
Device Sequence Number1
Product Code FPA
UDI-Device Identifier30610586028391
UDI-Public30610586028391
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K042172
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Administrator/Supervisor
Type of Report Initial
Report Date 10/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/04/2023
Device Model Number21-7230-24
Device Catalogue Number21-7230-24
Device Lot Number3586836
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/15/2019
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/26/2022
Initial Date FDA Received10/25/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/19/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age75 YR
Patient SexMale
-
-